In clinical terms, Romano et al. found an increased proportion of M-MDSC, PMN-MDSC, and CD34+ MDSC subpopulations in the peripheral blood of 60 newly diagnosed Hodgkin's lymphoma (HL) patients compared to healthy controls. The gene discussed is CD34; the disease is Hodgkins lymphoma.